RhumbLine Advisers’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.08M | Sell |
171,265
-25,431
| -13% | -$356K | ﹤0.01% | 1715 |
|
|
2026
Q1 | $1.85M | Buy |
196,696
+4,773
| +2% | +$52.4K | ﹤0.01% | 1899 |
|
|
2025
Q4 | $2.38M | Sell |
191,923
-9,877
| -5% | -$131K | ﹤0.01% | 1770 |
|
|
2025
Q3 | $2.89M | Sell |
201,800
-1,357
| -0.7% | -$18.6K | ﹤0.01% | 1711 |
|
|
2025
Q2 | $2.49M | Buy |
203,157
+9,822
| +5% | +$143K | ﹤0.01% | 1770 |
|
|
2025
Q1 | $4.25M | Sell |
193,335
-7,599
| -4% | -$179K | ﹤0.01% | 1441 |
|
|
2024
Q4 | $4.56M | Sell |
200,934
-6,726
| -3% | -$147K | ﹤0.01% | 1470 |
|
|
2024
Q3 | $3.77M | Sell |
207,660
-9,459
| -4% | -$219K | ﹤0.01% | 1568 |
|
|
2024
Q2 | $6.33M | Buy |
217,119
+17,628
| +9% | +$523K | 0.01% | 1263 |
|
|
2024
Q1 | $7.07M | Sell |
199,491
-12,169
| -6% | -$487K | 0.01% | 1234 |
|
|
2023
Q4 | $9.22M | Sell |
211,660
-12,790
| -6% | -$503K | 0.01% | 1102 |
|
|
2023
Q3 | $8.57M | Sell |
224,450
-4,328
| -2% | -$182K | 0.01% | 1065 |
|
|
2023
Q2 | $9.41M | Sell |
228,778
-5,277
| -2% | -$254K | 0.01% | 1040 |
|
|
2023
Q1 | $13.4M | Sell |
234,055
-2,342
| -1% | -$132K | 0.02% | 819 |
|
|
2022
Q4 | $13.3M | Buy |
236,397
+11,781
| +5% | +$600K | 0.02% | 795 |
|
|
2022
Q3 | $9.52M | Buy |
224,616
+8,524
| +4% | +$437K | 0.01% | 910 |
|
|
2022
Q2 | $11.7M | Buy |
216,092
+16,421
| +8% | +$986K | 0.02% | 823 |
|
|
2022
Q1 | $12.8M | Sell |
199,671
-3,972
| -2% | -$262K | 0.02% | 834 |
|
|
2021
Q4 | $13.6M | Buy |
203,643
+4,237
| +2% | +$287K | 0.02% | 807 |
|
|
2021
Q3 | $13.7M | Sell |
199,406
-4,422
| -2% | -$312K | 0.02% | 788 |
|
|
2021
Q2 | $13.9M | Sell |
203,828
-2,510
| -1% | -$177K | 0.02% | 810 |
|
|
2021
Q1 | $14.3M | Sell |
206,338
-2,273
| -1% | -$154K | 0.02% | 774 |
|
|
2020
Q4 | $13.5M | Buy |
208,611
+1,822
| +0.9% | +$98K | 0.02% | 750 |
|
|
2020
Q3 | $9.77M | Sell |
206,789
-5,614
| -3% | -$267K | 0.02% | 790 |
|
|
2020
Q2 | $9.98M | Buy |
212,403
+2,748
| +1% | +$135K | 0.02% | 773 |
|
|
2020
Q1 | $9.37M | Buy |
209,655
+16,953
| +9% | +$890K | 0.02% | 692 |
|
|
2019
Q4 | $11.2M | Sell |
192,702
-393
| -0.2% | -$23.4K | 0.02% | 763 |
|
|
2019
Q3 | $11.6M | Sell |
193,095
-1,419
| -0.7% | -$84.5K | 0.02% | 708 |
|
|
2019
Q2 | $10.9M | Sell |
194,514
-12,408
| -6% | -$639K | 0.02% | 730 |
|
|
2019
Q1 | $11.5M | Buy |
206,922
+142
| +0.1% | +$7.23K | 0.02% | 698 |
|
|
2018
Q4 | $9.33M | Buy |
206,780
+53,258
| +35% | +$2.92M | 0.02% | 750 |
|
|
2018
Q3 | $10.1M | Sell |
153,522
-2,689
| -2% | -$167K | 0.02% | 676 |
|
|
2018
Q2 | $10.1M | Sell |
156,211
-4,874
| -3% | -$302K | 0.02% | 681 |
|
|
2018
Q1 | $8.91M | Buy |
161,085
+2,794
| +2% | +$146K | 0.02% | 716 |
|
|
2017
Q4 | $7.58M | Buy |
158,291
+22,293
| +16% | +$1.09M | 0.02% | 826 |
|
|
2017
Q3 | $6.87M | Buy |
135,998
+5,136
| +4% | +$264K | 0.01% | 847 |
|
|
2017
Q2 | $7.13M | Sell |
130,862
-1,739
| -1% | -$83K | 0.02% | 806 |
|
|
2017
Q1 | $5.59M | Buy |
132,601
+32,867
| +33% | +$1.4M | 0.01% | 935 |
|
|
2016
Q4 | $4.28M | Buy |
99,734
+7,160
| +8% | +$291K | 0.01% | 1011 |
|
|
2016
Q3 | $3.82M | Buy |
92,574
+6,672
| +8% | +$280K | 0.01% | 1034 |
|
|
2016
Q2 | $3.43M | Sell |
85,902
-11,014
| -11% | -$396K | 0.01% | 1021 |
|
|
2016
Q1 | $3.26M | Buy |
96,916
+6,320
| +7% | +$197K | 0.01% | 1077 |
|
|
2015
Q4 | $3.07M | Buy |
90,596
+5,640
| +7% | +$176K | 0.01% | 1100 |
|
|
2015
Q3 | $2.53M | Sell |
84,956
-8,357
| -9% | -$261K | 0.01% | 1186 |
|
|
2015
Q2 | $2.57M | Sell |
93,313
-1,591
| -2% | -$42.4K | 0.01% | 1238 |
|
|
2015
Q1 | $2.39M | Buy |
94,904
+5,444
| +6% | +$129K | 0.01% | 1280 |
|
|
2014
Q4 | $1.98M | Sell |
89,460
-122
| -0.1% | -$2.47K | 0.01% | 1352 |
|
|
2014
Q3 | $1.82M | Buy |
89,582
+122
| +0.1% | +$2.43K | 0.01% | 1383 |
|
|
2014
Q2 | $1.72M | Buy |
89,460
+6,490
| +8% | +$121K | 0.01% | 1482 |
|
|
2014
Q1 | $1.56M | Sell |
82,970
-929
| -1% | -$17.9K | ﹤0.01% | 1507 |
|
|
2013
Q4 | $1.64M | Buy |
83,899
+636
| +0.8% | +$11.7K | ﹤0.01% | 1493 |
|
|
2013
Q3 | $1.37M | Sell |
83,263
-1,882
| -2% | -$30.2K | ﹤0.01% | 1567 |
|
|
2013
Q2 | $1.27M | Buy |
+85,145
| New | +$1.25M | ﹤0.01% | 1605 |
|
Other funds holding IART
RCMNY
PCMI
RhumbLine Advisers's IART Position: Q2 2026 in Review
RhumbLine Advisers reduced its Integra LifeSciences (IART) stake by 13% in Q2 2026, selling an estimated $356K and leaving 171,265 shares worth $3.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1715.
RhumbLine Advisers first reported a position in IART in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.3M in Q1 2021. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.
- RhumbLine Advisers held 171,265 shares of Integra LifeSciences worth $3.08M as of Q2 2026.
- RhumbLine Advisers sold 25,431 Integra LifeSciences shares in Q2 2026, an estimated $356K.
- Integra LifeSciences made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1715 holding.
- RhumbLine Advisers first reported a position in Integra LifeSciences in Q2 2013 and has held it in 53 quarters since.
- RhumbLine Advisers's Integra LifeSciences position peaked at $14.3M in Q1 2021.
- 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.